Data / Form D filings / Cavion, Inc.
Cavion, Inc.: Form D filings
Cavion, Inc., a biotechnology company in Charlottesville, VA, filed 3 Form D notices with the SEC between 2013 and 2017. The latest, on January 12, 2017, reports $22.3 million sold of a $31.5 million offering to 19 investors.
Find out what Cavion, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 600 EAST WATER STREET, SUITE E, Charlottesville, VA, 22902
- Phone
- (434) 989-6299
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1348076
The full lists. Form D filings in Virginia: 771 rows, $38.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 12, 2017 | New notice | $31,512,867 | $22,312,867 | $9,200,000 | 19 | Dec 28, 2016 | sec.gov |
| Jun 10, 2014 | Amendment | Indefinite | $12,837,500 | Indefinite | 54 | Nov 7, 2007 | sec.gov |
| Jan 15, 2013 | Amendment | Indefinite | $9,287,500 | Indefinite | 50 | Nov 7, 2007 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Henry J Skinner | Director | |
| Sergei J Petukhov | Director | |
| Anne J Heldreth | Executive Officer | |
| Steve J Hall | Director | |
| Andrew J Krouse | Executive Officer, Director | |
| David E Gibson | Director |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Jan 9, 2017 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cavion, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.